KRTL BioTech

Imperial Brands warns of lower annual profit due to U.S. FDA ban

Imperial Brands warns of lower annual profit due to U.S. FDA ban

Tobacco group Imperial Brands said on Wednesday it expects full-year adjusted earnings to be slightly lower than last year due to a U.S. regulatory ban on some flavors of cartridge-based vapor devices and weaker consumer demand.